This review discusses management strategies and features of multiple myeloma, highlighting therapeutic advancements.
Autologous stem-cell transplantation and agents such as thalidomide, lenalidomide, and bortezomib have changed the management of myeloma and extended overall survival. This review discusses both the biologic features and the management of multiple myeloma.
No takes yet. Share an insight, caveat, or question.
Palumbo et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: